Similar articles

• Insulin-antagonistic effects of counterregulatory hormones: clinical and mechanistic aspects.

  Smith U, Lager I. Smith U, et al. Diabetes Metab Rev. 1989 Sep;5(6):511-25. doi: 10.1002/dmr.5610050604. Diabetes Metab Rev. 1989. PMID: 2670491 Review. No abstract available.
• Pancreatic beta-cell growth and diabetes mellitus.

  Swenne I. Swenne I. Diabetologia. 1992 Mar;35(3):193-201. doi: 10.1007/BF00400917. Diabetologia. 1992. PMID: 1563578 Review. No abstract available.
• [Hormones of counter-regulation and metabolism of carbohydrates].

  Luyckx A, Scheen A, Castillo M, Jandrain B, Paolisso G, Henrivaux P, Lefèbvre P. Luyckx A, et al. Journ Annu Diabetol Hotel Dieu. 1985:35-52. Journ Annu Diabetol Hotel Dieu. 1985. PMID: 2577976 Review. French. No abstract available.
• Hyperinsulinemia and central adiposity: influence of chronic insulin therapy in type 1 diabetes.

  Kabadi UM, Vora A, Kabadi M. Kabadi UM, et al. Diabetes Care. 2000 Jul;23(7):1024-5. doi: 10.2337/diacare.23.7.1024. Diabetes Care. 2000. PMID: 10895862 No abstract available.
• Diabetes mellitus and insulin receptors.

  Krans HM. Krans HM. Neth J Med. 1985;28(2):59-62. Neth J Med. 1985. PMID: 3919324 Review. No abstract available.